Sharone Sabo

Sharone Sabo practices at Schweiger Dermatology in Great Neck, New York.

Sharone Sabo's NPI, 1710440615, was assigned on April 9, 2019. Sharone Sabo holds New York license 023356.

Sharone Sabo's primary practice is Schweiger Dermatology, at 825 Northern Blvd, Great Neck, NY 11021 in Nassau County. The practice phone is (929) 470-5354.

Sharone Sabo's primary practice is Schweiger Dermatology in Great Neck, New York. The medical group on file is Schweiger Dermatology Group. Dmand AI also links Sharone Sabo to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sharone Sabo practices. Vendor and product names are available with a free account.

Physician assistant is Sharone Sabo's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Sharone Sabo is licensed in New York.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, itchy rashes, minor head injury, minor injury to a limb and psoriasis among the conditions Sharone Sabo treats.

CMS data shows 622 Medicare services from Sharone Sabo across 12 procedure codes in 2024, for 173 Medicare patients. Medicare paid $28,630 for them. Every service was in an office.

CMS counts 173 Medicare patients who saw Sharone Sabo in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sharone Sabo's median patient age at 44, with 55% women.

In 2024, Sharone Sabo wrote 577 Medicare Part D claims for 195 patients. 90% of them were for generic drugs. CMS names the drug for 464 of them, across 14 drugs with 11 or more claims each, at $15,586 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Sharone Sabo for performance year 2024, reported as part of a group. Sharone Sabo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 47 general payments to Sharone Sabo from 13 drug and device companies in 2025. Food and beverage make up the largest share, 90% of the total. Sanofi and Genzyme US Companies paid the most, $277.